
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Cancer cell-derived type I interferons instruct tumor monocyte polarization
Dylan Kwart, Jing He, Subhashini Srivatsan, et al.
Cell Reports (2022) Vol. 41, Iss. 10, pp. 111769-111769
Closed Access | Times Cited: 26
Dylan Kwart, Jing He, Subhashini Srivatsan, et al.
Cell Reports (2022) Vol. 41, Iss. 10, pp. 111769-111769
Closed Access | Times Cited: 26
Showing 1-25 of 26 citing articles:
Senescence drives immunotherapy resistance by inducing an immunosuppressive tumor microenvironment
Damien Maggiorani, Oanh Lê, Véronique Lisi, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 36
Damien Maggiorani, Oanh Lê, Véronique Lisi, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 36
A developmental constraint model of cancer cell states and tumor heterogeneity
Ayushi Patel, Itai Yanai
Cell (2024) Vol. 187, Iss. 12, pp. 2907-2918
Closed Access | Times Cited: 27
Ayushi Patel, Itai Yanai
Cell (2024) Vol. 187, Iss. 12, pp. 2907-2918
Closed Access | Times Cited: 27
Defining and using immune archetypes to classify and treat cancer
Alexis J. Combes, Bushra Samad, Matthew F. Krummel
Nature reviews. Cancer (2023) Vol. 23, Iss. 7, pp. 491-505
Closed Access | Times Cited: 34
Alexis J. Combes, Bushra Samad, Matthew F. Krummel
Nature reviews. Cancer (2023) Vol. 23, Iss. 7, pp. 491-505
Closed Access | Times Cited: 34
Cholesterol-binding motifs in STING that control endoplasmic reticulum retention mediate anti-tumoral activity of cholesterol-lowering compounds
Bao‐cun Zhang, Marlene Fyrstenberg Laursen, Lili Hu, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 13
Bao‐cun Zhang, Marlene Fyrstenberg Laursen, Lili Hu, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 13
Exploiting temporal aspects of cancer immunotherapy
Rachael M. Zemek, Valsamo Anagnostou, Inês Pires da Silva, et al.
Nature reviews. Cancer (2024) Vol. 24, Iss. 7, pp. 480-497
Closed Access | Times Cited: 13
Rachael M. Zemek, Valsamo Anagnostou, Inês Pires da Silva, et al.
Nature reviews. Cancer (2024) Vol. 24, Iss. 7, pp. 480-497
Closed Access | Times Cited: 13
Cancer cells impair monocyte-mediated T cell stimulation to evade immunity
Anais Elewaut, Guillem Estivill, Felix Bayerl, et al.
Nature (2024)
Open Access | Times Cited: 9
Anais Elewaut, Guillem Estivill, Felix Bayerl, et al.
Nature (2024)
Open Access | Times Cited: 9
Specific molecular weight of Lycium barbarum polysaccharide for robust breast cancer regression by repolarizing tumor-associated macrophages
Mengqiu Liu, Chun‐Jie Bao, Xiaofei Liang, et al.
International Journal of Biological Macromolecules (2024) Vol. 261, pp. 129674-129674
Closed Access | Times Cited: 8
Mengqiu Liu, Chun‐Jie Bao, Xiaofei Liang, et al.
International Journal of Biological Macromolecules (2024) Vol. 261, pp. 129674-129674
Closed Access | Times Cited: 8
Targeting tumor monocyte-intrinsic PD-L1 by rewiring STING signaling and enhancing STING agonist therapy
Huan Song, Lin Chen, Xuanxuan Pan, et al.
Cancer Cell (2025) Vol. 43, Iss. 3, pp. 503-518.e10
Open Access | Times Cited: 1
Huan Song, Lin Chen, Xuanxuan Pan, et al.
Cancer Cell (2025) Vol. 43, Iss. 3, pp. 503-518.e10
Open Access | Times Cited: 1
Biophysical and biochemical aspects of immune cell–tumor microenvironment interactions
Shoham Benmelech, Thien Le, M. McKay, et al.
APL Bioengineering (2024) Vol. 8, Iss. 2
Open Access | Times Cited: 7
Shoham Benmelech, Thien Le, M. McKay, et al.
APL Bioengineering (2024) Vol. 8, Iss. 2
Open Access | Times Cited: 7
Rapid recruitment and IFN-I–mediated activation of monocytes dictate focal radiotherapy efficacy
Sirimuvva Tadepalli, Derek R. Clements, Sanjana Saravanan, et al.
Science Immunology (2023) Vol. 8, Iss. 84
Open Access | Times Cited: 13
Sirimuvva Tadepalli, Derek R. Clements, Sanjana Saravanan, et al.
Science Immunology (2023) Vol. 8, Iss. 84
Open Access | Times Cited: 13
Poly(alkylideneamine) Dendrimer Nanogels Codeliver Drug and Nucleotide To Alleviate Anticancer Drug Resistance through Immunomodulation
Yue Gao, Zhijun Ouyang, Gaoming Li, et al.
ACS Materials Letters (2024) Vol. 6, Iss. 2, pp. 517-527
Closed Access | Times Cited: 4
Yue Gao, Zhijun Ouyang, Gaoming Li, et al.
ACS Materials Letters (2024) Vol. 6, Iss. 2, pp. 517-527
Closed Access | Times Cited: 4
Vax-Innate: improving therapeutic cancer vaccines by modulating T cells and the tumour microenvironment
Faezzah Baharom, Dalton Hermans, Lélia Delamarre, et al.
Nature reviews. Immunology (2024)
Closed Access | Times Cited: 4
Faezzah Baharom, Dalton Hermans, Lélia Delamarre, et al.
Nature reviews. Immunology (2024)
Closed Access | Times Cited: 4
Elucidating stearoyl metabolism and NCOA4-mediated ferroptosis in gastric cancer liver metastasis through multi-omics single-cell integrative mendelian analysis: advancing personalized immunotherapy strategies
Zhongqiu Yang, Yuquan Chen, Yaping Miao, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Zhongqiu Yang, Yuquan Chen, Yaping Miao, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
The role of type I interferon signaling in myeloid anti-tumor immunity
Sofie Patrizia Meyer, Rebekka Bauer, Bernhard Brüne, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Sofie Patrizia Meyer, Rebekka Bauer, Bernhard Brüne, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Anti-vascular endothelial growth factor treatment potentiates immune checkpoint blockade through a BAFF- and IL-12-dependent reprogramming of the TME
Mohamed-Reda Benmebarek, Cihan Oguz, Matthias Seifert, et al.
Immunity (2025)
Closed Access
Mohamed-Reda Benmebarek, Cihan Oguz, Matthias Seifert, et al.
Immunity (2025)
Closed Access
CD301b+ monocyte-derived dendritic cells mediate resistance to radiotherapy
Sirimuvva Tadepalli, Derek R. Clements, Hayley M. Raquer-McKay, et al.
The Journal of Experimental Medicine (2025) Vol. 222, Iss. 6
Open Access
Sirimuvva Tadepalli, Derek R. Clements, Hayley M. Raquer-McKay, et al.
The Journal of Experimental Medicine (2025) Vol. 222, Iss. 6
Open Access
Decoding STING’s roles in cancer: immunity, pain, dormancy, and autophagy
Huan‐Xin Lin, Ya‐ling Tang, Xinhua Liang
Molecular and Cellular Biochemistry (2025)
Closed Access
Huan‐Xin Lin, Ya‐ling Tang, Xinhua Liang
Molecular and Cellular Biochemistry (2025)
Closed Access
Delivery of Interferon β-Encoding Plasmid via Lipid Nanoparticle Restores Interferon β Expression to Enhance Antitumor Immunity in Colon Cancer
Yingcui Yang, Shixuan Bo, Liyan Liang, et al.
ACS Nano (2024)
Closed Access | Times Cited: 3
Yingcui Yang, Shixuan Bo, Liyan Liang, et al.
ACS Nano (2024)
Closed Access | Times Cited: 3
Myeloid progenitor dysregulation fuels immunosuppressive macrophages in tumors
Samarth Hegde, Bruno Giotti, Brian Y. Soong, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access | Times Cited: 3
Samarth Hegde, Bruno Giotti, Brian Y. Soong, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access | Times Cited: 3
DNA repair-dependent immunogenic liabilities in colorectal cancer: opportunities from errors
Vito Amodio, Pietro Paolo Vitiello, Alberto Bardelli, et al.
British Journal of Cancer (2024)
Open Access | Times Cited: 2
Vito Amodio, Pietro Paolo Vitiello, Alberto Bardelli, et al.
British Journal of Cancer (2024)
Open Access | Times Cited: 2
Harnessing type I interferon-mediated immunity to target malignant brain tumors
Juhee Lim, In Man Kang, Jeongwoo La, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 6
Juhee Lim, In Man Kang, Jeongwoo La, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 6
High Expression of CDCA7 in the Prognosis of Glioma and Its Relationship with Ferroptosis and Immunity
Yunhan Wang, Yu Zhao, Zongying Zhang, et al.
Genes (2023) Vol. 14, Iss. 7, pp. 1406-1406
Open Access | Times Cited: 5
Yunhan Wang, Yu Zhao, Zongying Zhang, et al.
Genes (2023) Vol. 14, Iss. 7, pp. 1406-1406
Open Access | Times Cited: 5
Allogeneic stem cells engineered to release interferon β and scFv-PD1 target glioblastoma and alter the tumor microenvironment
Ioulia Vogiatzi, Lucia Moreno-Lama, A R Lehmann, et al.
Cytotherapy (2024) Vol. 26, Iss. 10, pp. 1217-1226
Closed Access | Times Cited: 1
Ioulia Vogiatzi, Lucia Moreno-Lama, A R Lehmann, et al.
Cytotherapy (2024) Vol. 26, Iss. 10, pp. 1217-1226
Closed Access | Times Cited: 1
Epigenomic programming of peripheral monocytes determines their transcriptional response to the tumor microenvironment
Máté Kiss, László Halász, Éva Hadadi, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Máté Kiss, László Halász, Éva Hadadi, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Mapping the peripheral immune landscape of Parkinson’s disease patients with single-cell sequencing
Gaël Moquin‐Beaudry, Lovatiana Andriamboavonjy, Sébastien Audet, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Gaël Moquin‐Beaudry, Lovatiana Andriamboavonjy, Sébastien Audet, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access